On an ex­ec­u­tive hir­ing spree, Sarep­ta snags Bio­gen's Gilmore O'Neill as new CMO

Sarep­ta has snagged ex-Bio­gen ex­ec­u­tive Gilmore O’Neill to join the lead­er­ship as CMO, fill­ing the po­si­tion just one year af­ter its last CMO hire.

Last April, the com­pa­ny had brought in for­mer Re­gen­eron ex­ec Cather­ine Stehman-Breen to serve as its chief med­ical of­fi­cer, de­spite her in­ex­pe­ri­ence with Duchenne drugs. At the time, then-CEO Ed Kaye point­ed to her “ex­ten­sive ex­pe­ri­ence in glob­al de­vel­op­ment, clin­i­cal op­er­a­tions and re­search across mul­ti­ple ther­a­peu­tic ar­eas” as rea­son­ing for her hire. But it ap­pears Stehman-Breen qui­et­ly left Sarep­ta just 8 months lat­er, al­though Sarep­ta nev­er is­sued a press re­lease re­gard­ing her de­par­ture.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER